Literature DB >> 22728504

A case of warfarin-induced eosinophilia.

Masakazu Teragaki1, Hitomi Kawano, Ryojiro Makino, Keisuke Inoue, Yoshinori Sai, Mitsuharu Hosono, Shigefumi Suehiro, Mikio Okamura.   

Abstract

Warfarin is widely used in clinical practice all over the world. We report a man in whom prominent eosinophilia appeared after the initiation of warfarin administration following aortic valve replacement. Laboratory data following the administration and discontinuation of warfarin suggested that this drug was responsible for the eosinophilia. It is important to recognize the possibility of warfarin-induced hypereosinophilia as a latent adverse effect even when there are no clinical signs or symptoms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728504     DOI: 10.2169/internalmedicine.51.7138

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Association between absolute blood eosinophil count and CKD stages among cardiac patients.

Authors:  Rui Ishii; Shu-Ichi Fujita; Shun Kizawa; Kazushi Sakane; Hideaki Morita; Michishige Ozeki; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  Heart Vessels       Date:  2014-10-18       Impact factor: 2.037

2.  Warfarin-induced Eosinophilia in a Child with urkitt Lymphoma: A Case Report.

Authors:  Kourosh Goudarzipour; Farid Ghazizadeh; Hesameddin Hoseini Tavassol; Behdad Behnam
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

3.  Urbanization and anticoagulant poisons promote immune dysfunction in bobcats.

Authors:  Laurel E K Serieys; Amanda J Lea; Marta Epeldegui; Tiffany C Armenta; Joanne Moriarty; Sue VandeWoude; Scott Carver; Janet Foley; Robert K Wayne; Seth P D Riley; Christel H Uittenbogaart
Journal:  Proc Biol Sci       Date:  2018-01-31       Impact factor: 5.349

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.